Home

Articles from AskBio Inc. (AskBio)

AskBio Announces 6 Presentations at the European Society of Gene and Cell Therapy 32nd Annual Meeting
By AskBio Inc. (AskBio) · Via GlobeNewswire · October 2, 2025
First European Participants Randomized in AskBio Phase 2 Gene Therapy Trial of AB-1005 for Parkinson’s Disease
By AskBio Inc. (AskBio) · Via GlobeNewswire · September 22, 2025
AskBio Announces Completion of Enrollment in Phase 1 Clinical Trial of AB-1005 Gene Therapy for Multiple System Atrophy-Parkinsonian Type (MSA-P)
By AskBio Inc. (AskBio) · Via GlobeNewswire · September 17, 2025
AskBio Announces Publication of Complete Results of Phase 1b Trial of AB-1005 Gene Therapy in Participants with Parkinson’s Disease in Movement Disorders
By AskBio Inc. (AskBio) · Via GlobeNewswire · May 27, 2025